(Q44696507)

English

Value-based differential pricing: efficient prices for drugs in a global context

scientific article published on 11 December 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Value-based differential pricing: efficient prices for drugs in a global context (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Patricia Danzon

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Adrian Towse

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jorge Mestre-Ferrandiz

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

11 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Health Economics

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

294-301

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

On international cost-sharing of pharmaceutical R&D.

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

Value based pricing for NHS drugs: an opportunity not to be missed?

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

Drug pricing and value in oncology

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

Differential pricing for pharmaceuticals: reconciling access, R&D and patents

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

An economic justification for open access to essential medicine patents in developing countries

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

Endogenous cost-effectiveness analysis and health care technology adoption

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

Innovation and The Welfare Effects of Public Drug Insurance

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

21 January 2018

Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

7 January 2021

based on heuristic

inferred from DOI database lookup

Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic foundations of cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness analysis and innovation

1 reference

https://api.crossref.org/works/10.1002%2FHEC.3021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEC.3021

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44696507&oldid=2032829378"